Charles River Laboratories (CRL)

SG&A Expenses

$753.54M

TTM · Period ending: · USD

CRL logo

CRL SG&A Expenses

Latest reported$753.54M
CRL TTM SG&A Expenses ($51.20M → $753.54M)
High-resolution chart · PNG

CRL sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Charles River Laboratories SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
753,543,000
716,195,000
734,572,000
742,645,000
764,269,000
742,511,000
751,003,000
752,437,000
729,333,000
759,300,000
747,855,000
750,353,000
757,958,000
689,911,000
665,098,000
609,570,000
574,429,000
614,219,000
619,919,000
618,840,000
598,556,000
554,767,000
528,935,000
515,500,000
516,720,000
524,949,000
517,622,000
494,942,000
478,466,000
463,056,000
443,854,000
431,496,000
410,891,000
384,180,000
371,717,000
375,638,000
368,860,000
375,513,000
367,548,000
350,528,000
341,103,000
311,961,000
300,414,000
290,987,000
279,238,000
275,663,000
269,033,000
255,673,000
246,100,000
233,263,000
225,695,000
218,345,000
214,489,000
209,470,000
208,248,000
203,011,000
202,309,000
199,618,000
198,648,000
206,461,000
234,121,000
252,152,000
259,476,000
266,682,000
242,806,000
234,148,000
233,995,000
228,228,000
228,587,000
233,084,000
230,226,000
231,422,000
228,781,000
223,794,000
217,491,000
207,775,000
197,139,000
191,078,000
180,795,000
188,075,000
189,842,000
180,881,000
182,999,000
168,187,000
150,030,000
138,180,000
121,448,000
105,906,000
102,088,000
96,217,000
90,983,000
88,212,000
87,232,000
85,270,000
83,303,000
80,883,000
77,876,000
73,774,000
68,315,000
65,599,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.